Gossamer Bio, Inc. - Common Stock (NQ:GOSS)

0.3646 -0.0253 (-6.49%)

Streaming Delayed Price Updated: 2:45 PM EDT, Apr 23, 2026 Add to My Watchlist

Price and Volume

Volume	3,076,562
Open	0.3921
Bid (Size)	0.3646 (3,500)
Ask (Size)	0.3654 (700)
Prev. Close	0.3899
Today's Range	0.3600 - 0.3921
52wk Range	0.3200 - 3.870
Shares Outstanding	75,993,532
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines – GOSS

April 21, 2026

From Pomerantz LLP

Via GlobeNewswire

GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Overstated Trial Prospects: Levi & Korsinsky

April 21, 2026

From Levi & Korsinsky, LLP

Via Business Wire

Performance

YTD	-87.3%	-87.3%
1 Month	-2.3%	-2.3%
3 Month	-86.7%	-86.7%
6 Month	-83.5%	-83.5%
1 Year	-55.9%	-55.9%

More News

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 21, 2026

From Schall Law

Via GlobeNewswire

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 17, 2026

From Schall Law

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Gossamer Investors that a Class Action Lawsuit Has Been Filed Against Gossamer Bio, Inc. (NASDAQ:GOSS) and Encourages Investors with Large Losses to Contact the Firm

April 15, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines – GOSS

April 14, 2026

From Pomerantz LLP

Via GlobeNewswire

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 14, 2026

From Schall Law

Via GlobeNewswire

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 10, 2026

From Schall Law

Via GlobeNewswire

Deadline Approaching: Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

April 08, 2026

From Law Offices of Howard G. Smith

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines – GOSS

April 07, 2026

From Pomerantz LLP

Via GlobeNewswire

GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Overstated Trial Prospects: Levi & Korsinsky

April 07, 2026

From Levi & Korsinsky, LLP

Via Business Wire

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Gossamer Bio, Inc. (GOSS) Shareholders To Inquire About Securities Fraud Class Action

April 07, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 07, 2026

From Schall Law

Via GlobeNewswire

Law Offices of Frank R. Cruz Encourages Gossamer Bio, Inc. (GOSS) Shareholders To Inquire About Securities Fraud Class Action

April 06, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

Law Offices of Howard G. Smith Encourages Gossamer Bio, Inc. (GOSS) Shareholders To Inquire About Securities Fraud Class Action

April 06, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Investigation Into Gossamer Bio, Inc. (GOSS) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

April 03, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

April 03, 2026

From Law Offices of Howard G. Smith

Via Business Wire

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 03, 2026

From Schall Law

Via GlobeNewswire

Gossamer Bio, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – GOSS

April 03, 2026

From DJS LAW GROUP

Via Business Wire

Securities Fraud Investigation Into Gossamer Bio, Inc. (GOSS) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

April 02, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 02, 2026

From The Schall Law Firm

Via Business Wire

Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Gossamer Bio, Inc. (NASDAQ:GOSS) and Encourages Investors with Large Losses to Contact the Firm

April 01, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Investor Notice: Robbins LLP Informs Investors of the Gossamer Bio, Inc. Class Action Lawsuit

April 01, 2026

From Robbins LLP

Via Business Wire

GOSS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026

April 01, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Gossamer Bio, Inc. – GOSS

March 24, 2026

From Pomerantz LLP

Via GlobeNewswire

Frequently Asked Questions

Is Gossamer Bio, Inc. - Common Stock publicly traded?

Yes, Gossamer Bio, Inc. - Common Stock is publicly traded.

What exchange does Gossamer Bio, Inc. - Common Stock trade on?

Gossamer Bio, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Gossamer Bio, Inc. - Common Stock?

The ticker symbol for Gossamer Bio, Inc. - Common Stock is GOSS on the Nasdaq Stock Market

What is the current price of Gossamer Bio, Inc. - Common Stock?

The current price of Gossamer Bio, Inc. - Common Stock is 0.3646

When was Gossamer Bio, Inc. - Common Stock last traded?

The last trade of Gossamer Bio, Inc. - Common Stock was at 04/23/26 02:45 PM ET

What is the market capitalization of Gossamer Bio, Inc. - Common Stock?

The market capitalization of Gossamer Bio, Inc. - Common Stock is 27.71M

How many shares of Gossamer Bio, Inc. - Common Stock are outstanding?

Gossamer Bio, Inc. - Common Stock has 28M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.